CRISPR Therapy
Gene editing therapy using CRISPR-Cas9. Casgevy (exa-cel) is the first approved CRISPR therapy, for sickle cell disease and beta-thalassemia.
No Treatments found for this treatment modalitie.
Gene editing therapy using CRISPR-Cas9. Casgevy (exa-cel) is the first approved CRISPR therapy, for sickle cell disease and beta-thalassemia.
No Treatments found for this treatment modalitie.